Orchestra BioMed Holdings share price logo

Orchestra BioMed Holdings

NASDAQ: OBIO

Small Cap

$5.68

-0.23

(-3.81%)

as on

Orchestra BioMed Holdings Stock Performance

as on November 3, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $5.66
    $6.02
    downward going graph

    0.35%

    Downside

    5.99%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.46
    $6.50
    downward going graph

    39.08%

    Downside

    14.44%

    Upside

    downward going graph

Orchestra BioMed Holdings share price movements today

Previous Close
$5.91
Open
$5.96
Volume
441.0K
Market Cap
$355.2M
Day's Low - High
$5.66 - $6.02
52 Week Low - High
$3.46 - $6.50

Orchestra BioMed Holdings Historical Returns

1 Month Return
-0.67 %
3 Month Return
+ 48.49 %
1 Year Return
+ 51.54 %
3 Year Return
+ 12.36 %
5 Year Return
0 %

Orchestra BioMed Holdings Stock Fundamentals & Key Indicators

Check Orchestra BioMed Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$355.2M

EPS (TTM)

-0.99

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.97

Industry PE ratio

-7.33

PEG Ratio

-0.09

EBITDA

-57.1M

Revenue (TTM)

32.0M

Profit Margin

99.32%

Return On Equity TTM

-125.93%

Orchestra BioMed Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Orchestra BioMed Holdings with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$355.2MNA-5.9799.32%0.00%
Neutral$88.5B-36.40%-27.78-12.57%0.00%
StrongBuy$141.7B208.09%32.2786.04%0.00%
Buy$95.5B45.26%19.7685.77%0.40%

Stock Returns calculator for Orchestra BioMed Holdings Stock including INR - Dollar returns

The Orchestra BioMed Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Orchestra BioMed Holdings investment value today

Current value as on today

₹1,55,780

Returns

₹55,780

(+55.78%)

Returns from Orchestra BioMed Holdings Stock

₹45,641 (+45.64%)

Dollar Impact

₹10,139 (+10.14%)

Analyst Recommendation on Orchestra BioMed Holdings Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Orchestra BioMed Holdings. Average target price of $12.43

Orchestra BioMed Holdings Share Price Target

Get share price movements and forecasts by analysts on Orchestra BioMed Holdings.

What analysts predicted

54.3%UPSIDE

Target Price

$12.43

Current Price

$5.68

Analyzed by

2 Analysts

High

$15

Target

$12.43

Low

$11

Orchestra BioMed Holdings target price $12.43, a slight upside of 54.3% compared to current price of $5.68. According to 2 analysts rating.

Indian Investors' Interest in Orchestra BioMed Holdings Stock

Search interest for Orchestra BioMed Holdings Stock has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-52% versus previous 30 day period

Orchestra BioMed Holdings Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
0
0
0
30
0
0
Gross Profit
0
0
0
0
0
0
0
30
0
0
Operating Income
-12
-14
-16
-16
-18
-19
-20
6
-22
-22
EBITDA
-12
-13
-15
-15
-18
-19
-20
7
-19
-23
Interest Expense
-
-
-
-
-
-
0
0
0
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-12
-13
-15
-15
-18
-19
-20
6
-20
-23
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-12
-13
-15
-15
-18
-19
-20
6
-20
-23
Net Profit Margin
68.32%
82.58%
94.34%
93.11%
94.93%
94.50%
94.31%
99.84%
16.36%
71.59%

Orchestra BioMed Holdings Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Total Revenue
5
0
3
2
2
33
Gross Profit
5
0
3
2
2
33
Operating Income
-18
-21
-32
-51
-64
-51
EBITDA
-18
-21
-33
-48
-60
-51
Interest Expense
-
0
-
-
-
1
Depreciation
0
0
0
0
0
0
Income Before Tax
-21
-23
-33
-49
-61
-52
Income Tax Expense
-
-
-
-
-
-
Net Income
-21
-23
-33
-49
-61
-52
Net Profit Margin
97.46%
125.45%
90.89%
93.26%
92.27%
99.43%

Orchestra BioMed Holdings Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-12
-13
-15
-15
-18
-19
-20
6
-20
-23
Operating Cash Flow
-10
-13
-10
-13
-16
-15
-14
-2
-22
-19
Investing Cash Flow
33
5
10
0
12
16
-38
-17
10
-23
Financing Cash Flow
-10
0
0
15
0
0
76
12
5
34
Change in Cash
11
-7
0
1
-3
0
23
-7
-6
-7

Orchestra BioMed Holdings Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Net Income
-21
-23
-33
-49
-61
-52
Operating Cash Flow
-26
-19
-29
-46
-50
-48
Investing Cash Flow
26
13
-64
10
13
-26
Financing Cash Flow
10
-3
103
46
29
88
Change in Cash
10
-10
9
10
-8
12

Global Institutional Holdings in Orchestra BioMed Holdings

Check out the Institutions with significant holdings in Orchestra BioMed Holdings.

Funds
Holdings
RTW INVESTMENTS, LP
15.90%
Joseph Edelman
8.38%
Vanguard
3.71%
VANGUARD INDEX FUNDS
3.28%
iShares
2.62%

Orchestra BioMed Holdings News & Key Events

  • img

    Today's Timeline - 01 October

    Thu, 06:20 PM

    -

    Orchestra BioMed surpasses full enrollment in BACKBEAT trial, exceeding target with 330 patients randomized across 81 sites.

Insights on Orchestra BioMed Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, OBIO stock has moved up by 48.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 211.3% return, outperforming this stock by 198.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 716.3% return, outperforming this stock by 664.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 6.24M → -23.75M (in $), with an average decrease of 223.1% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 30.91M → 88.0K (in $), with an average decrease of 59.8% per quarter

About Orchestra BioMed Holdings

Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease. The company's offerings also encompass FreeHold retractors, which are solutions for minimally invasive surgical procedures. Orchestra BioMed has formed key alliances to advance its products: a strategic collaboration with Medtronic focuses on developing and commercializing BackBeat CNT for pacemaker-indicated patients suffering from hypertension. Additionally, a partnership with Terumo Corporation is dedicated to the development and market introduction of Virtue SAB for artery disease. The company's headquarters are located in New Hope, Pennsylvania.
OrganisationOrchestra BioMed Holdings
Headquarters150 Union Square Drive, New Hope, PA, 18938, US
IndustryBiotechnology
CEODavid Hochman

Key Management of Orchestra BioMed Holdings

Name

Title

Dr. Yuval Hay Mika D.Sc, Ph.D.

GM & CTO of Bioelectronic Therapies

Dr. Hans-Peter Stoll M.D., Ph.D.

Senior VP & Medical Director

Mr. Bob Laughner

Senior Vice President of Regulatory & Quality

Mr. Juan Lorenzo

Senior Vice President of Product Development

Mr. David P. Hochman

Founder, Chairman of the Board of Directors & CEO

Mr. Andrew Lawrence Taylor M.B.A.

Chief Financial Officer

Mr. William Reed Little

Executive Vice President of Corporate Development & Strategy

Ms. Lisa Daniels

Vice President of Human Resources

Dr. Avraham Matityahu Fischer M.D.

Senior Vice President of Medical Affairs & Innovation

Mr. Darren R. Sherman

Founder, President, COO & Director

FAQs

What is Orchestra BioMed Holdings share price today?

Orchestra BioMed Holdings share price today is $5.68 as on at the close of the market. Orchestra BioMed Holdings share today touched a day high of $6.02 and a low of $5.66.

What is the 52 week high and 52 week low for Orchestra BioMed Holdings share?

Orchestra BioMed Holdings share touched a 52 week high of $6.50 on and a 52 week low of $3.46 on . Orchestra BioMed Holdings stock price today i.e. is closed at $5.68,which is 12.62% down from its 52 week high and 64.16% up from its 52 week low.

What is Orchestra BioMed Holdings's market capitalisation today?

Orchestra BioMed Holdings market capitalisation is $0.00T as on .

How to invest in Orchestra BioMed Holdings Stock (OBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Orchestra BioMed Holdings on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Orchestra BioMed Holdings Stock (OBIO) from India?

Indian investors can start investing in Orchestra BioMed Holdings (OBIO) shares with as little as ₹94.9000015258789 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.00 in Orchestra BioMed Holdings stock (as per the Rupee-Dollar exchange rate as on ). Based on Orchestra BioMed Holdings share’s latest price of $5.68 as on November 3, 2026 at 2:29 am IST, you will get 1.7606 shares of Orchestra BioMed Holdings. Learn more about fractional shares .